Flahy uses knowledge graphs to support AI-powered healthcare
SiliconANGLE Devony Hof
Flahy is using knowledge graphs to help its AI make healthcare decisions. The bet is that connecting more context can point patients to the right test or treatment.
Based on reporting by SiliconANGLE, Devony Hof — read the original for the full story.
Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error
Flahy Inc. is taking a graph-first approach to AI in healthcare, using connected biological and clinical data to help decide what happens next for a patient. Jagjit Singh, the company’s founder and CEO, says the point is not just to collect more information, but to make the model understand which facts matter and what they imply.
That idea shows up in the way Flahy thinks about clinical decision support. Singh described a patient with a genetic mutation and a high cholesterol marker, then asked how a new clinical signal might change treatment. That, he argued, is not a simple data lookup. It is a graph problem, because the system has to trace relationships across a messy set of signals before it can suggest a route forward.
Flahy says it has spent years building a graph-based information database and training its model to recognize those relationships. The company also works with graph technology vendors, including Neo4j Inc., and says it has built proprietary engines to handle one of the harder parts: folding wearable-device readings into the same structure as other health data so changes can be tracked over time.
Singh’s bigger point is that healthcare AI needs to explain itself. Flahy’s consumer product, FlahyLife, combines biological and health information to guide prevention, early detection and treatment selection. The company says it is working with clinical laboratories and health systems to improve clinical decision-making, close care gaps and get the right people to the right test at the right time. That is a very practical promise, and also a very demanding one.
The interview aired on theCUBE as part of the theCUBE + NYSE Wired: AI Luminaries series, where Singh framed the whole problem as a matter of connecting the graph correctly so the system can reason correctly.
My take — AI-written commentary, not fact-checked reporting
Graph talk in healthcare is easy to sell because it sounds careful, and healthcare does need careful. But the real test is whether these systems can stay useful when the data gets ugly, incomplete and contradictory, which is most of the time. The industry keeps pretending explanation is a bonus; in medicine, it’s the product.
Read more about this at: SiliconANGLE